Array BioPharma Inc. (Nasdaq: ARRY) announced that its Chief Medical Officer, John Yates, M.D., presented additional positive results from a Phase 2 clinical trial evaluating the efficacy of ARRY-797, a novel small molecule pan-cytokine inhibitor, in patients with post-surgical dental pain at the American Pain Society's 27th Annual Scientific Meeting in Tampa, Florida.

According to a study published in the open-access journal PLoSONE, the ancient human ancestor species Paranthropusboisei did not actually eat the type of food that issuggested by the size and shape of its teeth. Professor of anthropologyPeter Ungar (J. William Fulbright College of Arts and Sciences,University of Arkansas) and colleagues used microscopy andfractal analysis to analyze tooth marks on the ancient species.

With Mother's Day around the corner, the American Dental Association (ADA) wants to remind mothers-to-be that maintaining good oral health is an important part of overall health, especially during pregnancy. Research suggests there may be an association between maternal gum disease and pre-term birth and low birth weight babies. In addition, a recent study says that pregnant women with gum disease may be more likely to develop gestational diabetes.

BDA Masterclass, a dedicated new business education programme for dentists from the British Dental Association that is supported by the British Dental Trade Association, will be introduced to the profession at the 2008 British Dental Conference and Exhibition at the Manchester Central Convention Complex.

Medtronic, Inc. (NYSE: MDT) and Scil Technology GmbH announced a development, licensing and supply agreement between Medtronic and Scil Technology. The agreement focuses on development of Scil's biologic rhGDF-5 (recombinant human Growth and Differentiating Factor 5) dental regenerative technology for use in bone regeneration for dental implant placement and treatment of periodontal disease.